| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 12/30/2009 | WO2009158698A2 Targeted delivery of imaging probes for in vivo cellular imaging |
| 12/30/2009 | WO2009158328A1 Method for in vivo measurement of reverse cholesterol transport |
| 12/30/2009 | WO2009157561A1 Polymer/metal complex composite having mri contrast ability and mri contrasting and/or antitumor composition using the same |
| 12/30/2009 | WO2009156743A2 Magnetic microbubbles, methods of preparing them and their uses |
| 12/30/2009 | WO2009156445A2 Use of cobalt ferrites as contrast agents for magnetic resonance |
| 12/30/2009 | WO2009098191A3 Method to produce hyperpolarised amino acids and aminosulphonic acids |
| 12/30/2009 | WO2009076388A3 Targeting vector-phospholipid conjugates |
| 12/30/2009 | WO2009072079A3 Polymeric drug carrier for image-guided delivery |
| 12/30/2009 | WO2009061854A3 Multifunctional degradable nanoparticles with control over size and functionalities |
| 12/30/2009 | EP2137208A2 Compounds for diagnosing apoptosis |
| 12/30/2009 | EP1409482B1 Dye-sulfenates for dual phototherapy |
| 12/30/2009 | CN101616694A 18f fluoro-benzoyl labelled biological active coumpounds as diagnositic imaging agents as well as benzotriazol-1-yloxy-benzoyl, 2,5-dioxo-pyrrolidin-1-yloxy) benzoyl and trimethylammonio-benzoyl precu |
| 12/30/2009 | CN101616693A Marker genes for use in the identification of chondrocyte phenotypic stability and in the screening of factors influencing cartilage production |
| 12/30/2009 | CN101616692A Polychromatic, diversely-sized particles for angiography |
| 12/30/2009 | CN101612408A B ultrasonic coupler and preparation method thereof |
| 12/30/2009 | CN101612407A Polymer nanoparticle magnetic resonance contrast agent and preparing method thereof |
| 12/30/2009 | CN100574811C Particle analog adjuvant for high-intensity focusing ultrasonic therapy and its uses |
| 12/30/2009 | CN100574810C Plasmid adjuvant for high-intensity focusing ultrasonic therapy and its uses |
| 12/30/2009 | CN100574809C Fluorocarbon emulsion analog adjuvant for high-intensity focusing ultrasonic therapy and its uses |
| 12/30/2009 | CN100574808C Liver targeted high molecule magnetic resonance image-forming contrast synthesizing method |
| 12/30/2009 | CA2728960A1 Polymer-metal complex composite having mri contrast ability and mri contrasting and/or antitumor composition using the same |
| 12/29/2009 | US7638598 ErbB interface peptidomimetics and methods of use thereof |
| 12/29/2009 | CA2189848C Photocleavable agents and conjugates for the detection and isolation of biomolecules |
| 12/24/2009 | US20090318746 Lubricious echogenic coatings |
| 12/24/2009 | US20090317335 Hybrid Nanomaterials as Multimodal Imaging Contrast Agents |
| 12/24/2009 | US20090317334 Optical detection method or imaging method of implanted cells |
| 12/24/2009 | US20090317333 Protein kinase a reporters useful in high throughput assays |
| 12/24/2009 | US20090317331 Method of Identifying Partial Agonists of the A2A Receptor |
| 12/24/2009 | US20090317330 Diagnosis and treatment of diseases involving platelet activation |
| 12/24/2009 | US20090317329 Anticoagulation agent and uses thereof |
| 12/24/2009 | US20090317325 Diagnostic Substance and Method for the Analysis of Metabolism Processes in the Brain |
| 12/23/2009 | WO2009155335A2 Conjugates of 19f mr imaging tracers and chemotherapeutic agents for drug quantification and drug dose individualization |
| 12/23/2009 | WO2009155133A1 Method for testing efficacy of treatment of neurologic disorders |
| 12/23/2009 | WO2009154963A1 Composition for therapy and imaging of cancer and associated methods |
| 12/23/2009 | WO2009154425A2 Multimodal imaging method using nano-emulsion comprising optical nano-particles and perfluorocarbons |
| 12/23/2009 | WO2009154283A1 Antibody directed against calcified globule, and use thereof |
| 12/23/2009 | WO2009154025A1 ANTIBODY AGAINST OXIDIZED LDL/β2GPI COMPLEX AND USE OF THE SAME |
| 12/23/2009 | WO2009152625A1 Method and device for characterizing the effect of a skin treatment agent on skin |
| 12/23/2009 | WO2009135178A3 Methods for production and use of substance-loaded erythrocytes (s-les) for observation and treatment of microvascular hemodynamics |
| 12/23/2009 | WO2009129649A8 Biocompatible polymer and magnetic nanoparticle with biocompatibility |
| 12/23/2009 | WO2009122443A3 A tumor model system useful to study multistage cancer |
| 12/23/2009 | WO2009078000A3 Imaging dyes and use thereof |
| 12/23/2009 | WO2009071444A3 Imaging method |
| 12/23/2009 | WO2009053596A3 Novel method for preparing nanoparticles covered with a gem-bisphosphonate stabilising layer coupled to hydrophilic biodistribution ligands |
| 12/23/2009 | WO2008151612A3 Device suitable for introducing into human and/or animal bodies |
| 12/23/2009 | EP2135942A1 Method for suppressing immune system response to transplanted tissue or cells |
| 12/23/2009 | EP2135613A1 Remedy and diagnostic for mitochondrial dysfunction brain disease |
| 12/23/2009 | EP2134642A1 In vivo tumor targeting and spectroscopic detection with surface-enhanced raman nanoparticle tags |
| 12/23/2009 | EP2134367A2 Integrated photoactive peptides and uses thereof |
| 12/23/2009 | CN101608212A Application of schizandrin A in detection of cytochrome P4503A enzymatic activity and detection method thereof |
| 12/23/2009 | CN101607913A 改进的螯合剂缀合物 Improved chelator conjugate |
| 12/23/2009 | CN100571787C Para-hydrogen labelled agents and their use in magnetic resonance imaging |
| 12/23/2009 | CA2728473A1 Antibody against oxidized ldl/.beta.2gpi complex and use of the same |
| 12/23/2009 | CA2725934A1 Novel substituted indoles |
| 12/22/2009 | US7635688 Gene expression vectors; intensifier dor sequence determiantion; induce immunology response; viricides |
| 12/22/2009 | US7635682 Tumor activated prodrugs |
| 12/22/2009 | US7635488 Comprising support having electrostatic properties wherein periphery of support is coated with adhesive material, and all or part of non-adhesive surface of support is covered with biologically active substance in form of particles that adhere by electrostatic forces; drug delivery |
| 12/22/2009 | US7635464 Selective targeting of apoptotic cells |
| 12/22/2009 | CA2327465C Bipolar lipids capable of delivering polyanions to cells |
| 12/22/2009 | CA2133833C Method and kit for imaging and treating organs and tissues |
| 12/17/2009 | WO2009152428A1 Quantitative analysis of in vivo mutation at the pig-a locus |
| 12/17/2009 | WO2009152426A1 Bilateral control of functions traditionally regulated by only serotonin or only dopamine |
| 12/17/2009 | WO2009151687A2 Dendrimer conjugates |
| 12/17/2009 | WO2009151627A2 Endosome-disrupting compostions and conjugates |
| 12/17/2009 | WO2009103744A3 Process for preparing a pharmaceutical formulation of contrast agents |
| 12/17/2009 | WO2009092062A9 Fluorescent imaging agents |
| 12/17/2009 | WO2009071460A3 New non-selective somatostatin analogues |
| 12/17/2009 | WO2009060403A3 Cest mri contrast agents based on non-spherical particles |
| 12/17/2009 | WO2008144931A8 Compositions and methods for modulating gated ion channels |
| 12/17/2009 | US20090312244 Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| 12/17/2009 | US20090311194 Methods and compositions for the production and use of magnetosomes |
| 12/17/2009 | US20090311193 Methods and reagents for in vivo imaging of cancer cell lines |
| 12/17/2009 | US20090311192 Core and core-shell nanoparticles containing iodine for x-ray imaging |
| 12/17/2009 | US20090311191 Imaging of atherosclerotic plaques using liposomal imaging agents |
| 12/17/2009 | US20090311190 Self-assembled, micropatterned, and radio frequency (rf) shielded biocontainers and their uses for remote spatially controlled chemical delivery |
| 12/17/2009 | US20090311189 Temperature-jump dynamic nuclear polarization |
| 12/17/2009 | US20090311188 In vivo methods of identifying compounds which target suppressed cancer cells |
| 12/17/2009 | US20090311187 Methods for predicting patient response to modulation of the Co-stimulatory pathway |
| 12/17/2009 | US20090311186 Method for controlling the therapy of patients suffering from cardiac insufficiency by means of in vitro determination of threshold values of vasoactive peptides |
| 12/17/2009 | US20090311185 Peptide having antianxiety activity and screening method therefor |
| 12/17/2009 | US20090311184 High penetration prodrug compositions of peptides and peptide-related compounds |
| 12/17/2009 | US20090311183 Metalloproteinase 12 binding proteins |
| 12/17/2009 | US20090311182 Macromolecular Delivery Systems for Non-Invasive Imaging, Evaluation and Treatment of Arthritis and Other Inflammatory Diseases |
| 12/17/2009 | US20090311181 Engineered Anti-Prostate Stem Cell Antigen (PSCA) Antibodies for Cancer Targeting |
| 12/17/2009 | US20090311180 Protein Isoforms and Uses Thereof |
| 12/17/2009 | US20090311179 Selective Targeting of Apoptotic Cells |
| 12/16/2009 | EP2133100A1 MTB32A Antigen of mycobacterium tuberculosis with inactivated active site and fusion proteins thereof |
| 12/16/2009 | EP2132227A1 Composition of labeled and non-labeled monoclonal antibodies |
| 12/16/2009 | EP2131871A2 Use of metal nanoparticles for diagnosing alzheimer disease |
| 12/16/2009 | EP2131870A1 Magnetic resonance imaging contrast agents comprising zinc-containing magnetic metal oxide nanoparticles |
| 12/16/2009 | EP2131869A2 Fluorescent emulsions for optical imaging |
| 12/16/2009 | EP2131857A2 Method of preparing an immunologically-active adjuvant-bound dried vaccine composition |
| 12/16/2009 | CN101601863A Method for constructing diabetes mellitus animal model |
| 12/16/2009 | CN100570365C Antibody or neutrophil-mediated ozone generation |
| 12/15/2009 | US7632646 Tuberculosis diagnostic test |
| 12/15/2009 | US7632486 Efficacy of drugs in the treatment of malignant tumors such as breast cancer, prostatic cancer and lung cancer that cause the bone metastasis are diagnosed using a marker that reflects the activity of osteoblasts and a marker that reflects the action of osteoclasts |
| 12/15/2009 | CA2386782C Bioadhesive nanoparticulate compositions having cationic surface stabilizers |
| 12/15/2009 | CA2243088C Humanized green fluorescent protein genes and methods |
| 12/10/2009 | WO2009148598A1 Polymersomes, colloidosomes, liposomes, and other species associated with fluidic droplets |
| 12/10/2009 | WO2009148121A1 Novel molecular assembly, molecular probe for molecular imaging and molecular probe for drug delivery system using the same, and molecular imaging system and drug delivery system |